ロード中...
Mechanisms of resistance to pemetrexed in non-small cell lung cancer
Currently, lung cancer has remained the most common cause of cancer death while non-small cell lung cancer (NSCLC) accounts for the most of all lung cancer cases. Regardless of multiple existing managements, chemotherapy regimens are still the mainstay of treatment for NSCLC, where pemetrexed has sh...
保存先:
| 出版年: | Transl Lung Cancer Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6976363/ https://ncbi.nlm.nih.gov/pubmed/32010588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.10.14 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|